To include your compound in the COVID-19 Resource Center, submit it here.

NEA, Pfizer back Complexa in $62M series C round

Rare disease play Complexa

Read the full 48 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE